SPRING VALLEY, N.Y., Nov. 29 /PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc. will be presenting at the First Albany Capital Annual Growth Conference on Tuesday, December 6, at 4:00 pm EST at The Mandarin Oriental Hotel in New York City.
The audio-only live webcast will be accessible through the First Albany Capital website at http://www.wsw.com/webcast/fac2/prx/ or through the Par Pharmaceutical website at http://www.parpharm.com. A replay will be available at the same link address for 90 days after the conference and will begin immediately after the presentation.
Par Pharmaceutical Companies, Inc. develops, manufactures and markets generic pharmaceuticals through its principal subsidiary, Par Pharmaceutical, Inc. The company is also developing an additional line of branded pharmaceutical products, the first of which is Megace(R) ES, for specialty markets. Par currently manufactures, markets or licenses more than 90 prescription drugs. For press release and other company information, please visit http://www.parpharm.com.
Par Pharmaceutical Companies, Inc.
CONTACT: Stephen J. Mock or Cecelia C. Heer, both for Par PharmaceuticalCompanies, Inc., +1-201-802-4000
